The global medical radiation shielding market size was USD 1.51 billion in 2023, calculated at USD 1.61 billion in 2024 and is expected to be worth around USD 3.08 billion by 2034. The market is slated to expand at 6.70% CAGR from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Medical Radiation Shielding Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Medical Radiation Shielding Market Revenue and Volume, by Product Type, 2024-2034
8.1.1 X-ray Shields
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. MRI Shields
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Gamma Shields
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Neutron Shields
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Medical Radiation Shielding Market Revenue and Volume, by Solution, 2024-2034
9.1.1. Radiation Therapy Shielding
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Diagnostic Shielding
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Medical Radiation Shielding Market Revenue and Volume, by End User, 2024-2034
10.1.1. Hospitals and Diagnostic Centers
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Research Institutes
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Other End Users
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Solution (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)
12.1. A&L Shielding
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Amray Medical
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. ESCO Technologies Inc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. ETS-Lindgren
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Gaven Industries Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. MAVIG GmbH
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Global Partners in Shielding Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Marshield
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Nelco Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Radiation Protection Products Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample